Aging, energy, and oxidative stress in neurodegenerative diseases - PubMed (original) (raw)
Review
Aging, energy, and oxidative stress in neurodegenerative diseases
M F Beal. Ann Neurol. 1995 Sep.
Abstract
The etiology of neurodegenerative diseases remains enigmatic; however, evidence for defects in energy metabolism, excitotoxicity, and for oxidative damage is increasingly compelling. It is likely that there is a complex interplay between these mechanisms. A defect in energy metabolism may lead to neuronal depolarization, activation of N-methyl-D-aspartate excitatory amino acid receptors, and increases in intracellular calcium, which are buffered by mitochondria. Mitochondria are the major intracellular source of free radicals, and increased mitochondrial calcium concentrations enhance free radical generation. Mitochondrial DNA is particularly susceptible to oxidative stress, and there is evidence of age-dependent damage and deterioration of respiratory enzyme activities with normal aging. This may contribute to the delayed onset and age dependence of neurodegenerative diseases. There is evidence for increased oxidative damage to macromolecules in amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease. Potential therapeutic approaches include glutamate release inhibitors, excitatory amino acid antagonists, strategies to improve mitochondrial function, free radical scavengers, and trophic factors. All of these approaches appear promising in experimental studies and are now being applied to human studies.
Similar articles
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal MF. Beal MF. Ann Neurol. 1992 Feb;31(2):119-30. doi: 10.1002/ana.410310202. Ann Neurol. 1992. PMID: 1349466 Review. - Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. Calabrese V, et al. J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review. - Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K, Robotka H, Toldi J, Vécsei L. Sas K, et al. J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25. J Neurol Sci. 2007. PMID: 17462670 Review. - Mitochondria take center stage in aging and neurodegeneration.
Beal MF. Beal MF. Ann Neurol. 2005 Oct;58(4):495-505. doi: 10.1002/ana.20624. Ann Neurol. 2005. PMID: 16178023 Review. - Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
Calabrese V, Boyd-Kimball D, Scapagnini G, Butterfield DA. Calabrese V, et al. In Vivo. 2004 May-Jun;18(3):245-67. In Vivo. 2004. PMID: 15341181 Review.
Cited by
- Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life.
Bhattacharya K, Maiti S, Zahoran S, Weidenauer L, Hany D, Wider D, Bernasconi L, Quadroni M, Collart M, Picard D. Bhattacharya K, et al. Nat Commun. 2022 Oct 21;13(1):6271. doi: 10.1038/s41467-022-33916-3. Nat Commun. 2022. PMID: 36270993 Free PMC article. - Neurodegenerative disorders, metabolic icebergs, and mitohormesis.
Phillips MCL, Picard M. Phillips MCL, et al. Transl Neurodegener. 2024 Sep 6;13(1):46. doi: 10.1186/s40035-024-00435-8. Transl Neurodegener. 2024. PMID: 39242576 Free PMC article. Review. - Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.
Araujo JA, Studzinski CM, Head E, Cotman CW, Milgram NW. Araujo JA, et al. Age (Dordr). 2005 Mar;27(1):27-37. doi: 10.1007/s11357-005-4001-z. Epub 2005 May 2. Age (Dordr). 2005. PMID: 23598601 Free PMC article. - Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature.
Crutchfield KC, Dluzen DE. Crutchfield KC, et al. Neurotox Res. 2006 Jan;9(1):15-21. doi: 10.1007/BF03033303. Neurotox Res. 2006. PMID: 16464748 - Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.
Xia XG, Harding T, Weller M, Bieneman A, Uney JB, Schulz JB. Xia XG, et al. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10433-8. doi: 10.1073/pnas.181182298. Epub 2001 Aug 14. Proc Natl Acad Sci U S A. 2001. PMID: 11504916 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical